Search Results 751-760 of 16663 for supplement stack optimization

  1. A Study to Evaluate Trifluridine/Tipiracil Combined with Bevacizumab vs Trifluridine/Tipiracil to Treat Patients with Refractory Metastatic Colorectal Cancer - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic Health ... optimal dosages and risks/benefits. In the later phase (phase 3) ...

  2. Oncology (Medical) - Clinical trials

    Drugs & Supplements · Healthy Lifestyle · Mayo Clinic Health Letter & Books. For ... The purpose of this study is to improve patient care by optimizing and ...

  3. A Study Of The Effect, Safety, And Tolerability Of LJPC-501 In Patients With Catecholamine-Resistant Hypotension - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic Health ... optimal dosages and risks/benefits. In the later phase (phase 3) ...

  4. A Study to Test the Addition of Nivolumab to Chemotherapy to Treat Soft Tissue Sarcoma - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic Health ... optimal dosages and risks/benefits. In the later phase (phase 3) ...

  5. Study Evaluating The Safety And Efficacy Of Fenfluramine Hydrochloride Oral Solution As Adjunctive Therapy In Children With Doose Syndrome - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic Health ... optimal dosages and risks/benefits. In the later phase (phase 3) ...

  6. A Study Of Avatrombopag For The Treatment Of Thrombocytopenia In Patients With Chronic Liver Disease Undergoing An Elective Procedure - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic Health ... optimal dosages and risks/benefits. In the later phase (phase 3) ...

  7. A Study of Macitentan in Pulmonary Hypertension After Left Ventricular Assist Device Implantation - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic Health ... optimal dosages and risks/benefits. In the later phase (phase 3) ...

  8. A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Subjects With Select Advanced Malignancies - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic Health ... optimal dosages and risks/benefits. In the later phase (phase 3) ...

  9. A Study of the Effect of Myectomy on the Sudden Cardiac Death Risk in Hypertrophic Cardiomyopathy - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic Health Letter · Healthy Lifestyle. Featured conditions. Brain tumor, breast cancer ...

  10. A Study of The Impact of Predictive Modeling On Time to Palliative Care Review in an Inpatient Hospital Population - Mayo Clinic

    The purpose of this study is to assess the effectiveness and implementation of the Control Tower palliative care algorithm into hospital practice. Participation ...